lung cancer

Research in Review

Patient Navigators Increase Lung Cancer Screening Rates Among Smokers

06/08/2017

JCP Editors

A patient navigation program implemented in community health centers significantly increased lung cancer screening among underserved populations, according to research presented at the 2017 ASCO Annual Meeting (June...

A...

06/08/2017

Journal of Clinical Pathways

Research in Review

Flu Vaccine May Cause Adverse Events for Lung Cancer Patients on Immunotherapy

05/03/2017

JCP Editors

Patients with lung cancer who are treated with immunotherapy may be at increased risk of severe adverse events after receiving the seasonal influenza vaccination, according to results of a study presented at the...

...

05/03/2017

Journal of Clinical Pathways

Research in Review

Small Study Suggests Nivolumab Does Not Improve Outcomes in Patients With Lung Cancer and Liver Metastases

03/16/2017

JCP Editors

None of the patients in a study with lung cancer and hepatic metastases experienced an objective response in their liver tumors after anti-PD1 therapy, according to research presented at ASCO’s Society for...

None...

03/16/2017

Journal of Clinical Pathways

Research in Review

Best Treatment Course for Brain Metastases in EGFR Lung Cancer Identified

01/27/2017

JCP Editors

The best sequence of treatment strategies has been identified for patients with epidermal growth factor receptor (EGFR)-mutant lung cancer and brain metastases, according to an article published in the Journal of...

The...

01/27/2017

Journal of Clinical Pathways

Research in Review

Ibuprofen May Lower Risk of Lung Cancer Death Among Smokers

12/21/2016

JCP Editors

Regular ibuprofen intake may lower the risk of lung cancer death among individuals with current or past histories of smoking, according to a new study. ----- Related Content New Lung Cancer Biomarker...

...

12/21/2016

Journal of Clinical Pathways

Research in Review

Time to Surgery After NCRT Affects NSCLC Survival

10/07/2016

JCP Editors

Patients with stage IIIA non-small cell lung cancer (NSCLC) who undergo surgery later than 6 weeks after neoadjuvant chemoradiation (NCRT) may experience significantly lower overall survival, according to results...

...

10/07/2016

Journal of Clinical Pathways

Department

Trial Shows Precision Medicine Improves Cancer Survival

09/28/2016

JCP Editors

Data from the Paris-based Molecular Screening for Cancer Treatment Optimization (MOSCATO) trial demonstrates that establishing molecular portraits improves survival for patients with advanced cancer by tailoring...

Data...

09/28/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of September 11-17

09/14/2016

JCP Editors

In a study analyzing oxygen levels within cancer tumors, researchers found that adding which of the following drugs to standard care could help to prevent the development of treatment resistance in patients with...

In a...

09/14/2016

Journal of Clinical Pathways

Research in Review

Gene Assay May Predict Treatment Response in Lung Cancer

09/09/2016

JCP Editors

In a new study, researchers identified 14 centromere and kinetochore (CEN/KT) genes regulating genome integrity that were consistently overexpressed in a variety of cancers. This allowed the researchers to create the...

In a...

09/09/2016

Journal of Clinical Pathways

Research in Review

Factors Affecting 30-Day Mortality in Women With Breast and Lung Cancer

09/04/2016

JCP Editors

Researchers have identified several factors that may affect the risk of early mortality among patients with breast and lung cancer, according to a recent study. In a study published in The Lancet Oncology,...

...

09/04/2016

Journal of Clinical Pathways